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Abstract To investigate the molecular events controlling re-
verse cholesterol transport, we compared gene expression of
normal mouse liver to that of mice fed a long chain (LC) g-3
fatty acid-enriched diet. Using cDNA microarrays, we assessed
expression levels of 1176 genes, and we found that D-site bind-
ing protein (DBP) was three-fold increased in mice on a LC g-3
fatty acid-rich diet compared to controls. DBP is known to
increase transcriptional level of cholesterol 7K-hydroxylase
(C7K), the rate-limiting enzyme for bile acid production and
cholesterol excretion, and we found that C7K mRNA was also
up-regulated by LC g-3 fatty acids. Moreover, liver X receptor-
K, another transcription factor up-regulating C7K, was three- to
four-fold increased in liver of treated mice. On the other hand,
we demonstrated that bile acid and cholesterol excretion were
two-fold increased. These results show that LC g-3 fatty acids
control cholesterol metabolism in mice at a new endpoint.
/ 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Dietary n-3 polyunsaturated fatty acids (PUFA) have pro-
found e¡ects on hepatic gene transcription leading to signi¢-
cant changes in lipid metabolism. The g-3 PUFA-dependent
partitioning of metabolic fuels away from storage and to-
wards oxidation re£ects the fact that these fatty acids suppress
the expression of lipogenic genes, and simultaneously induce
the transcription of genes encoding proteins involved in lipid
oxidation and thermogenesis. It has been demonstrated that
the g-3 PUFA control of lipogenic gene transcription is due
to down-regulation in liver of sterol regulatory binding pro-
tein-1 (SREBP-1) mRNA and inhibition of the release of ma-
ture SREBP-1 from the endoplasmic reticulum [1]. On the
other hand, long chain (LC) g-3 PUFA act on lipid oxidation
and thermogenesis by functioning as ligands for peroxisome
proliferator-activated receptor-K (PPARK) [2^4], whereas
PPARK is also known to increase the transcriptional level
of lipoprotein lipase, which results in a faster catabolism of
triglyceride-rich lipoproteins. The consequence of LC g-3
PUFA liganding to PPARK, associated with the fact that
they decrease diacylglycerol acyltransferase mRNA, explains
why LC g-3 PUFA are used as a triglyceride-lowering drugs.
We and others have demonstrated that plasma high density
lipoprotein (HDL)-cholesterol and apolipoprotein (apo) A-I
and apoA-II concentrations decreased when the diet was sup-
plemented by LC g-3 PUFA [4,5]. The lowering of HDL-
cholesterol was associated with reduced liver apoA-I mRNA
levels through a PPARK-dependent pathway [4]. Furthermore
we demonstrated that mice fed a LC g-3 fatty acid-enriched
diet exhibited an increased uptake of HDL-cholesterol ester in
the liver, probably through an increase in scavenger receptor
B-1 (SR-B1) [5]. This e¡ect of g-3 PUFA on HDL metabo-
lism may contribute to their bene¢cial e¡ects on reverse cho-
lesterol transport and cardiovascular diseases.
In an attempt to identify new genes involved in the control
of lipid metabolism under a LC g-3 fatty acid-rich diet, we
compared the patterns of gene expression in control and
treated mouse liver using large-scale cDNA microarrays and
quantitative reverse transcriptase-polymerase chain reaction
(RT-qPCR) analysis. We found in treated mice an over-ex-
pression of D-site binding protein (DBP), liver X receptor-K
(LXRK) and cholesterol 7K-hydroxylase (C7K) as well as an
increase in bile acid and cholesterol excretion.
2. Materials and methods
2.1. Animals
Female mice, obtained from I¡a Credo (L’Arbresle, France), were
on the C57Black background. They were housed in a full-barrier
animal facility on a 12 h light/dark cycle, with free access to food
and water. Since g-3 fatty acids can be considered a possible supple-
mentation or treatment in human diet for their bene¢cial roles, we
decided in this study to add these fatty acids to the standard mouse
diet. Eight week old female mice were thus placed either on a regular
diet, or on a regular diet enriched in LC g-3 fatty acids for 16 weeks
as previously described [5]. The g-3-enriched diet contained 19% ei-
cosapentaenoic acid (20:5n-3) and 13% docosahexaenoic acid (22:6n-
3) from total fatty acids. Mice were fed the diet for 16 weeks. They
did not lose weight and had normal hepatic tests (ALAT, ASAT,
LDH) throughout the experiment. As the study described here was
part of a larger study (n=20 mice for each study group), we used ¢ve
mice on a standard diet and four mice on a LC g-3 fatty acid-rich
diet. The use of the research protocol was in accordance with the
French Ministry of Agriculture, section of Health and Animal Pro-
tection (approval 04476).
2.2. RNA isolation
Mouse livers were obtained from 6 month old female mice on a
standard diet (n=5) or a LC g-3 fatty acid-rich diet (n=4). Samples
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were immediately put into a Trizol0 solution (Gibco BRL, InVitro-
gen, Cergy, France) and stored at 380‡C pending RNA isolation.
Total RNAs were isolated according to Chomczynski and Sacchi [6]
from each individual liver. The amount of RNA was determined by
measuring absorption at 260 nm. Quality of the isolated RNAs was
controlled by the 260/280 nm ratio (1.8^2.0) and by denaturing gel
electrophoresis.
2.3. cDNA array procedures and analyses
Aliquots of RNAs from mice on a standard diet were pooled (un-
treated pool) and aliquots of RNAs from mice on a LC g-3 fatty
acid-rich diet were pooled (treated pool).
Samples of total RNA pools (5 Wg) were used to synthesize [K-
32P]dATP cDNA probes for hybridization according to the manufac-
turer’s procedure (Clontech, Palo Alto, CA, USA). The 32P-labelled
cDNA probes were further puri¢ed by column chromatography
(NucTrap0 Probe puri¢cation column, Stratagene, Amsterdam, The
Netherlands). The Atlas Mouse 1.2 Array, containing 1176 mouse
cDNAs, was purchased from Ozyme (Clontech). The probes (3U106
cpm/ml) were hybridized overnight (68‡C) on separate ¢lter arrays,
and washed according to the manufacturer’s protocol. After exposure
to a PhosphorImager screen (Molecular Dynamics, Sunnyvale, CA,
USA) for 2^4 days, the images were analyzed using the ImageQuaNT
software (Molecular Dynamics). Two di¡erent hybridizations were
performed with the untreated pool probes and with the treated pool
probes.
After subtraction of the background, signal values were normalized
by considering the mean ¢lter hybridization signal. No signals were
detected in the spots of plasmid or bacteriophage DNA, con¢rming
the speci¢city of the hybridization. For each gene, the treated/un-
treated ratio was calculated by dividing the average value obtained
for the two independent hybridizations performed with the treated
pool probes, by the average value of two independent hybridizations
performed with the untreated pool probes.
2.4. qPCR analysis
For performing qPCR, RNAs from each individual liver from
treated and untreated mice were reverse transcribed to cDNA using
random primers and GeneAmp0 RNA PCR kit (Applied Biosystems,
Courtaboeuf, France). The speci¢c primers and TaqMan0 probes
were designed using Primer Express (Applied Biosystems) or Primer3
software, and synthesized by Eurogentec (Seraing, Belgium). Probes
were double labelled with the £uorescent reporter dye 6-carboxy£uo-
rescein (FAM) covalently linked to the 5P end of the probe and the
quencher dye 6-carboxytetramethylrhodamine (TAMRA) attached to
the 3P end. qPCR was performed in 96 well reaction plates with
optical caps. Fluorescence was continuously followed for each reac-
tion. Gene expression was normalized for ribosomal 18S RNA
amount. The qPCR data are given as the mean of treated/untreated
ratios of gene expression (and S.E.M.) calculated from ampli¢cations
of cDNAs prepared from individual treated (n=4) and untreated
(n=5) mice. Moreover, ampli¢cations from each individual cDNA
were performed in duplicate and the duplicate data matched closely,
indicating that there was no technical problem with the qPCR; the
mean of the duplicates was used for the subsequent calculations (mean
treated/untreated ratios and S.E.M.).
2.5. Bile acid and cholesterol excretion
For measurement of the bile acid and cholesterol excretion, feces
samples from 10 treated or untreated mice were pooled and prepared
as described [7]. Brie£y, feces samples were lyophilized and ground to
a ¢ne powder which was extracted with 90% ethanol. The extract was
subsequently dried down completely and resuspended in 50% ethanol.
The bile acid and cholesterol contents of all samples were measured
colorimetrically using analysis kits (Sigma Diagnostics, L’Isle
d’Abeau-Chesnes, France; bioMe¤rieux, Marcy l’Etoile, France).
3. Results and discussion
3.1. cDNA arrays
Liver RNA samples obtained from four treated mice were
pooled as well as the samples from ¢ve untreated mice. They
were used to prepare 32P-labelled cDNA probes which were
then hybridized to individual Atlas 1.2 Arrays (Clontech) con-
taining cDNA for 1176 mouse genes. Two independent cDNA
array experiments were performed. 100% of the 1176 genes
gave a signal above the background value (data in pixels) in
both types of mice (http://cbi.labri.fr/outils/data/). Only 20
genes were signi¢cantly expressed di¡erentially in hepatic
samples from treated or untreated mice. Four genes gave a
ratio larger than two-fold and 16 genes had a ratio smaller
than 50% in treated mice (Table 1). Among the four genes up-
regulated in the livers from treated mice according to cDNA
array results, the three ¢rst genes gave reproducible hybridi-
zation values whereas the last one (platelet endothelial cell
Table 1
Genes di¡erentially expressed (transcriptional arrays) in livers from mice on an g-3-enriched diet for 16 weeks (treated) compared to livers
from control mice (untreated)
GenBank accession number Gene/protein name Treated/untreated ratioa
U29762 D-binding protein (albumin D box-binding protein) (DBP) 3.100
U28423 58 kDa inhibitor of RNA-activated protein kinase (P58IPK) 2.199
D78645 78 kDa glucose-regulated protein (GRP78) 2.139
L06039 CD31; platelet endothelial cell adhesion molecule 1 (PECAM-1) 2.056
X97052 MAPKK6; MAP kinase kinase 6 (MKK6) 0.498
D28492 caspase-2 precursor (CASP2) 0.497
U34960 transducin L2 subunit 0.497
AF069542 NF-UB essential modulator; IUB kinase Q subunit (IKK-Q) essential regulatory subunit 0.493
X76292 desert hedgehog homolog precursor (DHH); HHG3 0.491
X70472 myb-related protein B; B-myb; mybL2 0.480
U03279 PI3-K p110; phosphatidylinositol 3-kinase catalytic subunit 0.478
U10551 Gem-induced immediate early protein; Ras family member 0.441
AF033585 frizzled homolog 9 (FZD9) 0.439
U02887 DNA repair protein XRCC1 0.429
D31788 BST-1; lymphocyte di¡erentiation antigen CD38 0.422
Y14019 Rab-3b ras-related protein 0.393
U12273 DNA-(apurinic/apyrimidinic) lyase; AP endonuclease 1 (APEX nuclease; APEN;
APEX)
0.378
U92456 WBP6; pSK-SRPK1; WW domain binding protein 6 serine kinase for SR splicing
factors
0.375
U44088 T-cell death-associated protein (TDAG51) 0.350
U12273 DNA excision repair protein ERCC1 0.288
aRatios were calculated by dividing the average value (from two independent hybridizations) obtained for the control sample pool (n=5) by
the average value of the treated sample pool (n=4).
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adhesion molecule 1, PECAM-1) did not give close values in
the two experiments.
3.2. qPCR
qPCR analysis was used ¢rst to check array results and,
second, to explore further the metabolic pathways related to
lipid metabolism.
Table 2 shows that only the three ¢rst genes were found to
be at least two-fold up-regulated in the liver of treated mice.
These were the D-binding protein (also called albumin D box-
binding protein, DBP), the 58 kDa inhibitor of RNA-acti-
vated protein kinase (P58IPK) and the 78 kDa glucose-regu-
lated protein (GRP78). P58IPK is an inhibitor of RNA-acti-
vated protein kinase known to interfere in the regulation of
normal cellular processes such as signal transduction, cellular
di¡erentiation, growth and proliferation as well as gene ex-
pression at the transcriptional level [8]. GRP78 is an endo-
plasmic reticulum chaperone protein whose expression is in-
duced during oxidative stress [9]. Its induction is required to
maintain endoplasmic reticulum function, to facilitate protein
folding and thus to protect cells from the toxic consequences
of oxidative stress. It has been suggested that GRP78 may
protect the host cells against cell death by suppressing oxy-
radical accumulation and stabilizing mitochondrial functions
[10,11]. Omega-3 PUFA are believed to be molecular targets
for lipid peroxide formation due to their high degree of un-
saturation. Some authors have reported a protective role in
vivo for g-3 PUFA in combating free radicals [12,13]. Thus
the up-regulation of the GRP78 gene could explain, at least in
part, how g-3 PUFA would protect tissues from the e¡ects of
oxyradical accumulation. Moreover, GRP78 can form a com-
plex with caspase-7 and caspase-12 preventing activation and
release of caspase-12. It is noteworthy that the array results
showed that an g-3 diet decreased levels of mRNA encoding
di¡erent proteins involved in apoptosis, as caspase-2 precur-
sor (U0.497), caspase-7 (U0.531), and apoptotic protease ac-
tivating factor 1 (U0.614). The DBP, a member of the pro-
line- and acid-rich domain subfamily of basic/leucine zipper
proteins, accumulates according to a robust circadian rhythm
in liver and several other tissues [14]. It has been demon-
strated that DBP seems to be more a component of the cir-
cadian output pathway rather than a master gene of the clock
[15].
It has been shown that DBP is involved in the transcrip-
tional regulation of several hepatic genes [16]. In particular,
DBP is a positive regulator of the circadian expression of the
gene encoding cholesterol 7K-hydroxylase (C7K) [14,17], the
rate-limiting enzyme in the conversion of cholesterol to bile
acids [18], and steroid 15K-hydroxylase (S15KOH) [19], an
enzyme involved in liver steroid catabolism. That suggests
that DBP may play an important role in cholesterol homeo-
stasis through transcriptional regulation of C7K and S15KOH.
Other transcription factors have been shown to up-regulate
C7K and S15KOH genes, namely two nuclear receptors: the
liver X receptor K (LXRK) [20] and the pregnane X receptor K
(PXRK) [21] respectively. By qPCR, we showed that mRNAs
of LXRK, PXRK and RXRK (a receptor which forms active
heterodimers with LXRK and PXRK) are dramatically up-
regulated in the livers of treated mice as shown in Table 2.
Furthermore, we demonstrated by qPCR that C7K and
S15KOH mRNA levels were both two- to three-fold increased
in livers of treated mice (Table 2). In contrast, Pawar et al.
[22] concluded that LXRK was not a target for g-3 PUFA
regulation in rat livers because LXR-regulated transcripts
such as C7K were not up-regulated. However, their study
design was di¡erent from ours: the rats were fed a high car-
bohydrate diet supplemented with ¢sh oil at 10% w/w and
livers were removed V2 h after completing the meal. On
the other hand, K-linolenic acid, which is an g-3 fatty acid
precursor of LC g-3 PUFA, has been described to be able to
induce LXRK expression in vitro by two-fold [23]. The fact
that LC g-3 PUFA were shown, in this last study and ours, to
increase the transcriptional level of LXRK is particularly im-
portant because LXR is known to regulate transcripts encod-
ing proteins involved in HDL metabolism and reverse choles-
terol transport [24], such as scavenger receptor-B1 whose
mRNA was found two- to three-fold increased in liver from
mice fed a LC g-3 fatty acid-rich diet [5] and C7K. Besides
that, several authors have reported that C7K protein level and
Table 2
qPCR data concerning genes either found overexpressed in cDNA
array experiments or involved in cholesterol metabolism
Gene/protein name qPCR results
DBP 12.9U 9.40
P58IPK 3.20U 2.18
GRP78 2.96U 1.64
PECAM-1 0.75U 0.32
Cholesterol 7K-OH 2.27U 0.53
Steroid 15K-OH 2.37U 1.47
LXRK 3.41U 0.60
PXRK 6.88U 2.14
RXRK 8.72U 2.78
qPCR analysis shows the determination of the relative quantity of
mRNA from individual livers of four mice on a LC g-3 fatty acid-
enriched diet compared to mRNA from individual livers of ¢ve con-
trol mice. Target and endogenous control (18S) ampli¢cations were
done in duplicate and results were normalized to 18S. Data are ex-
pressed as the mean (U S.E.M.) of the treated/untreated ratio of
gene expression.
Fig. 1. Putative pathways of stimulation of bile acid and cholesterol
excretion by LC g-3 fatty acids. Thick arrows represent pathways
identi¢ed in this work. Thin arrows represent pathways identi¢ed in
the literature with corresponding references. It is presently unknown
whether stimulation of C7K as well as bile acid and cholesterol ex-
cretion by LC g-3 fatty acids represent a new additional pathway
or follow the presently identi¢ed pathways through LXRK and
DBP.
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activity are regulated primarily at the level of gene transcrip-
tion [17,25].
3.3. Bile acid and cholesterol excretion
We evaluated bile acid and cholesterol excretion in feces
samples from treated mice compared to untreated mice.
Mice on a LC g-3 fatty acid-rich diet excreted bile acid and
cholesterol two times more than untreated mice (0.101 versus
0.051 Wmol/g of feces and 0.80 versus 0.28 Wmol/g of feces,
respectively). For the ¢rst time, we demonstrated that mice on
a LC g-3 fatty acid-rich diet were able to up-regulate bile acid
and cholesterol excretion. Another study demonstrated that
incubation of cells with remnants derived from corn oil rich
in n-6 PUFA led to increased bile acid production, while
addition of palm oil remnants to the medium did not a¡ect
bile acid synthesis [26]. In our study, the most likely explana-
tion for the e¡ect on bile acid and cholesterol excretion is an
increase in C7K by LC g-3 PUFA through an induction of
DBP and LXR (Fig. 1). Since it has been established that the
control of lipogenic gene transcription by g-3 is mainly due to
a reduction of SREBP-1 in liver [1], and that PPARK has
probably a minor role in the lowering of triglyceride and
HDL-cholesterol levels by ¢sh oil in mice [4], our results sug-
gest the existence of a new pathway through which ¢sh oil
could exert its lipid-lowering action. In our previous study [5],
we reported that LC g-3 PUFA induce an increase in SR-B1
mRNA, suggesting an increase in SR-B1 amount at the sur-
face of liver cells. This e¡ect on the last step of reverse cho-
lesterol transport ^ an important mechanism by which HDL
are thought to reduce the development of atherosclerosis ^
could account, at least in part, for the bene¢cial e¡ect of diets
rich in LC g-3 PUFA reported in epidemiological studies. In
this study, we demonstrated for the ¢rst time an increase in
bile acid and cholesterol excretion from the body of treated
mice, probably through an increase in C7K secondary to DBP
and LXRK induction.
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